Manual Thrombus Aspiration Is Not Associated With Reduced Mortality in Patients Treated With Primary Percutaneous Coronary Intervention: An Observational Study of 10,929 Patients With ST-Segment Elevation Myocardial Infarction From the London Heart Attack Group.
575 - 584
JACC Cardiovasc Interv
MetadataShow full item record
OBJECTIVES: This study aimed to assess the impact of thrombus aspiration on mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention (PCI). BACKGROUND: The clinical effect of routine intracoronary thrombus aspiration before primary PCI in patients with ST-segment elevation myocardial infarction is uncertain. METHODS: We undertook an observational cohort study of 10,929 ST-segment elevation myocardial infarction patients from January 2005 to July 2011 at 8 centers across London, United Kingdom. Patients' details were recorded at the time of the procedure into local databases using the British Cardiac Intervention Society PCI dataset. Primary outcome was all-cause mortality at a median follow-up of 3.0 years (interquartile range: 1.2 to 4.6 years). RESULTS: In our cohort, 3,572 patients (32.7%) underwent thrombus aspiration during primary PCI. Patients who had thrombus aspiration were younger, had lower rates of previous myocardial infarction but were more likely to have poor left ventricular function. Procedural success rates were higher (90.9% vs. 89.2%; p=0.005) and in-hospital major adverse cardiac event rates were lower (4.4% vs. 5.5%; p=0.012) in patients undergoing thrombus aspiration. However, Kaplan-Meier analysis demonstrated no significant difference in mortality rates between patients with and without thrombus aspiration (14.8% aspiration vs. 15.3% PCI only; p=0.737) during the follow-up period. After multivariate Cox analysis (hazard ratio [HR]: 0.89, 95% confidence interval [CI]: 0.65 to 1.23) and the addition of propensity matching (HR: 0.85 95% CI: 0.60 to 1.20) thrombus aspiration was still not associated with decreased mortality. CONCLUSIONS: In this cohort of nearly 11,000 patients, routine thrombus aspiration was not associated with a reduction in long-term mortality in patients undergoing primary PCI, although procedural success and in-hospital major adverse cardiac event rates were improved.
AuthorsJones, DA; Rathod, KS; Gallagher, S; Jain, AK; Kalra, SS; Lim, P; Crake, T; Ozkor, M; Rakhit, R; Knight, CJ; Iqbal, MB; Dalby, MC; Malik, IS; Whitbread, M; Mathur, A; Redwood, S; MacCarthy, PA; Weerackody, R; Wragg, A
- College Publications 
Showing items related by title, author, creator and subject.
Computed tomography segmental calcium score (SCS) to predict stenosis severity of calcified coronary lesions. Pugliese, F; Hunink, MG; Meijboom, WB; Gruszczynsnka, K; Rengo, M; Zou, L; Baron, I; Dijkshoorn, ML; Krestin, GP; de Feyter, PJ (2015-09-14)To estimate the probability of ≥ 50% coronary stenoses based on computed tomography (CT) segmental calcium score (SCS) and clinical factors. The Institutional Review Board approved the study. A training sample of 201 ...
Quantitative computed tomographic coronary angiography: does it predict functionally significant coronary stenoses? Rossi, A; Papadopoulou, S-L; Pugliese, F; Russo, B; Dharampal, AS; Dedic, A; Kitslaar, PH; Broersen, A; Meijboom, WB; van Geuns, R-J;... (2014-01)BACKGROUND: Coronary lesions with a diameter narrowing ≥50% on visual computed tomographic coronary angiography (CTCA) are generally considered for referral to invasive coronary angiography. However, similar to invasive ...
Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in London. Iqbal, MB; Ilsley, C; Kabir, T; Smith, R; Lane, R; Mason, M; Clifford, P; Crake, T; Firoozi, S; Kalra, S;... (2014-11-01)BACKGROUND: It is estimated that up to two thirds of patients presenting with ST-segment-elevation myocardial infarction have multivessel disease. The optimal strategy for treating nonculprit disease is currently under ...